Pulse Biosciences CS (PLSE)

$14.04 +0.33 (2.41%)
Market Cap 937.23M
Revenue (ttm) 0.00
Net Income (ttm) -53.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 140,900
Avg Vol 176,202
Day's Range N/A - N/A
Shares Out 67.77M
Stochastic %K 36%
Beta 1.69
Analysts Sell
Price Target $22.00

Company Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cyc...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 510 906 4600
Address:
601 Brickell Key Drive, Suite 1080, Miami, United States
malphius
malphius Feb. 3 at 9:09 PM
$PLSE Kinda wild how nobody knows about this and imo it's about to explode.
1 · Reply
D_Clark
D_Clark Feb. 3 at 7:55 PM
$PLSE low float feel quiet accumulation possible if buyers step in
0 · Reply
LeisureSuitLarry
LeisureSuitLarry Feb. 3 at 3:57 PM
$PLSE
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Feb. 3 at 3:37 PM
$PLSE data is going to shft paradigm.
0 · Reply
Carl81
Carl81 Feb. 3 at 1:47 PM
$PLSE
0 · Reply
DisciplinedBoardCenter
DisciplinedBoardCenter Feb. 3 at 12:58 PM
$PLSE $ON Semiconductor interest
0 · Reply
TruthBroker2
TruthBroker2 Feb. 3 at 12:26 PM
$PLSE Team Pulse Congrats
1 · Reply
DARKP00L
DARKP00L Feb. 3 at 12:20 PM
$PLSE 07:16 on Feb. 03 2026 Pulse Biosciences To Highlight nPulse Technology In Late-Breaking Science Session And Live Case Transmission Featuring nPulse Cardiac Catheter Integrated With Abbott's EnSiteX 3D Mapping System At 31st Annual AF Symposium 2026 Meeting #tradeideas
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 3 at 11:41 AM
$PLSE RSI: 40.53, MACD: -0.1375 Vol: 0.45, MA20: 14.31, MA50: 14.01 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
malphius
malphius Feb. 3 at 12:28 AM
$PLSE my body (and wallet) is ready.
0 · Reply
Latest News on PLSE
Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

Feb 3, 2026, 7:00 AM EST - 18 hours ago

Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

Pulse Biosciences, Inc. (PLSE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 15, 2026, 1:46 AM EST - 20 days ago

Pulse Biosciences, Inc. (PLSE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Jan 9, 2026, 7:00 AM EST - 25 days ago

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

Jan 6, 2026, 7:00 AM EST - 4 weeks ago

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 4:05 PM EST - 5 weeks ago

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dec 19, 2025, 4:05 PM EST - 6 weeks ago

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

Dec 18, 2025, 7:00 AM EST - 6 weeks ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology

Dec 9, 2025, 7:00 AM EST - 2 months ago

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Nov 6, 2025, 4:05 PM EST - 3 months ago

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 11:01 PM EST - 3 months ago

Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 3 months ago

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

Oct 24, 2025, 7:00 AM EDT - 3 months ago

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Oct 22, 2025, 4:05 PM EDT - 3 months ago

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Oct 10, 2025, 7:00 AM EDT - 4 months ago

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Oct 7, 2025, 7:00 AM EDT - 4 months ago

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Pulse Biosciences' nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

Sep 10, 2025, 7:00 AM EDT - 5 months ago

Pulse Biosciences' nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

Sep 8, 2025, 7:00 AM EDT - 5 months ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

Sep 2, 2025, 7:00 AM EDT - 5 months ago

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Aug 26, 2025, 7:00 AM EDT - 5 months ago

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Pulse Biosciences, Inc. (PLSE) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 9:06 PM EDT - 6 months ago

Pulse Biosciences, Inc. (PLSE) Q2 2025 Earnings Call Transcript

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

Aug 12, 2025, 4:05 PM EDT - 6 months ago

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

Aug 1, 2025, 7:00 AM EDT - 6 months ago

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

Jul 29, 2025, 4:05 PM EDT - 6 months ago

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript

May 10, 2025, 11:02 PM EDT - 9 months ago

Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 9 months ago

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

May 6, 2025, 4:05 PM EDT - 9 months ago

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

May 1, 2025, 7:00 AM EDT - 9 months ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

Apr 24, 2025, 4:05 PM EDT - 10 months ago

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

Apr 23, 2025, 7:00 AM EDT - 10 months ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 7:46 PM EDT - 11 months ago

Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Mar 27, 2025, 4:05 PM EDT - 11 months ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

Mar 26, 2025, 4:05 PM EDT - 11 months ago

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

Mar 7, 2025, 8:00 AM EST - 11 months ago

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

Feb 20, 2025, 4:05 PM EST - 1 year ago

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

Feb 4, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

Pulse Biosciences' Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

Jan 30, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

Jan 21, 2025, 7:00 AM EST - 1 year ago

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

Pulse Biosciences' Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

Jan 13, 2025, 7:00 AM EST - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

Jan 10, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 3, 2025, 9:00 AM EST - 1 year ago

Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Dec 23, 2024, 4:30 PM EST - 1 year ago

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants

Dec 19, 2024, 8:00 AM EST - 1 year ago

Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants

Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery

Dec 17, 2024, 8:00 AM EST - 1 year ago

Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery

Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association

Oct 31, 2024, 2:25 PM EDT - 1 year ago

Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association

Pulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:42 PM EDT - 1 year ago

Pulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call Transcript

Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results

Oct 30, 2024, 4:05 PM EDT - 1 year ago

Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results

Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology

Oct 30, 2024, 4:02 PM EDT - 1 year ago

Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology

Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024

Oct 21, 2024, 8:00 AM EDT - 1 year ago

Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024

Pulse Biosciences Inc. (PLSE) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 6:50 PM EDT - 1 year ago

Pulse Biosciences Inc. (PLSE) Q2 2024 Earnings Call Transcript

Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results

malphius
malphius Feb. 3 at 9:09 PM
$PLSE Kinda wild how nobody knows about this and imo it's about to explode.
1 · Reply
D_Clark
D_Clark Feb. 3 at 7:55 PM
$PLSE low float feel quiet accumulation possible if buyers step in
0 · Reply
LeisureSuitLarry
LeisureSuitLarry Feb. 3 at 3:57 PM
$PLSE
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Feb. 3 at 3:37 PM
$PLSE data is going to shft paradigm.
0 · Reply
Carl81
Carl81 Feb. 3 at 1:47 PM
$PLSE
0 · Reply
DisciplinedBoardCenter
DisciplinedBoardCenter Feb. 3 at 12:58 PM
$PLSE $ON Semiconductor interest
0 · Reply
TruthBroker2
TruthBroker2 Feb. 3 at 12:26 PM
$PLSE Team Pulse Congrats
1 · Reply
DARKP00L
DARKP00L Feb. 3 at 12:20 PM
$PLSE 07:16 on Feb. 03 2026 Pulse Biosciences To Highlight nPulse Technology In Late-Breaking Science Session And Live Case Transmission Featuring nPulse Cardiac Catheter Integrated With Abbott's EnSiteX 3D Mapping System At 31st Annual AF Symposium 2026 Meeting #tradeideas
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 3 at 11:41 AM
$PLSE RSI: 40.53, MACD: -0.1375 Vol: 0.45, MA20: 14.31, MA50: 14.01 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
malphius
malphius Feb. 3 at 12:28 AM
$PLSE my body (and wallet) is ready.
0 · Reply
notreload_ai
notreload_ai Jan. 30 at 2:55 PM
Mizuho and Jefferies initiate coverage on $PLSE and $ENGN , highlighting growth potential, strong clinical data, and upcoming catalysts in biotech. https://notreload.xyz/wall-street-starts-coverage-on-plse-and-engn/
0 · Reply
LeisureSuitLarry
LeisureSuitLarry Jan. 30 at 1:12 PM
$PLSE
0 · Reply
BubbaHoTep
BubbaHoTep Jan. 28 at 9:21 PM
$PLSE my pulse is dropping
1 · Reply
TruthBroker2
TruthBroker2 Jan. 26 at 2:30 PM
$PLSE $SMMT
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Jan. 23 at 4:27 PM
$PLSE easy 5x from here Nfa. Gla.
1 · Reply
TruthBroker2
TruthBroker2 Jan. 22 at 2:21 PM
$PLSE $SMMT 💰
0 · Reply
Tjcmd
Tjcmd Jan. 21 at 11:43 AM
$PLSE fyi…
0 · Reply
TruthBroker2
TruthBroker2 Jan. 20 at 2:45 PM
$PLSE
0 · Reply
Easteregg
Easteregg Jan. 20 at 2:21 PM
$PLSE Get ready for...the SLAMMA JAMMA!
0 · Reply
TruthBroker2
TruthBroker2 Jan. 16 at 3:51 PM
$SMMT $PLSE
0 · Reply
bob2013
bob2013 Jan. 15 at 12:37 AM
$PLSE Paul Laviolette one of the best well spoken CEO’S around! My advice is to listen to the presentation if you have not. We will revolutionize this market, partnerships will be coming after February AF Symposium, getting closer with every passing quarter…..
2 · Reply
bob2013
bob2013 Jan. 14 at 1:40 PM
$PLSE Lots of good news and insights are on the way today.. (HE KNOWS)!!!
1 · Reply